Table 2. Classification of women with breast cancer according to their risk of infection from COVID-19.

Risk	Clinical-Demographic Criteria	Face-to-face follow-up
Low	- People younger than 40 without comorbidities	Onsite consultation at any time, with bio-security measures
Medium	- People aged 41 to 59 without comorbidities who are having active hormonal, immunological or radiotherapy treatment	Face-to-face consultation in case of high or moderate priority. Emphasis must be placed on biosecurity measures
High	- People aged 60 years or over with or without comorbidities - People undergoing active chemotherapy and/or corticosteroid treatment - People with at least 1 relevant comorbidity, independent of age	Avoid face-to-face consultations. Carry out all care remotely except in case of high priority, which must be referred immediately to the emergency department or the treating medic.